{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:23:33Z","timestamp":1791757413081,"version":"4.3.4"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T00:00:00Z","timestamp":1321920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/nrgastro.2011.210","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T10:37:47Z","timestamp":1321958267000},"page":"15-22","source":"Crossref","is-referenced-by-count":63,"title":["Gastroesophageal reflux disease\u2014from reflux episodes to mucosal inflammation"],"prefix":"10.1038","volume":"9","author":[{"given":"Arne","family":"Kandulski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,22]]},"reference":[{"key":"BFnrgastro2011210_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrgastro.2010.78","volume":"7","author":"RJ Badreddine","year":"2010","unstructured":"Badreddine, R. J. & Wang, K. K. Barrett esophagus: an update. Nat. Rev. Gastroenterol. Hepatol. 7, 369\u2013378 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nrgastro.2009.103","volume":"6","author":"RD Odze","year":"2009","unstructured":"Odze, R. D. Barrett esophagus: histology and pathology for the clinician. Nat. Rev. Gastroenterol. Hepatol. 6, 478\u2013490 (2009).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/gut.2004.051821","volume":"54","author":"J Dent","year":"2005","unstructured":"Dent, J., el-Serag, H. B., Wallander, M. A. & Johansson, S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54, 710\u2013717 (2005).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","volume":"5","author":"HB el-Serag","year":"2007","unstructured":"el-Serag, H. B. Time trends of gastroesophageal reflux disease: a systematic review. Clin. Gastroenterol. Hepatol. 5, 17\u201326 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000080308","volume":"22","author":"I Wiklund","year":"2004","unstructured":"Wiklund, I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig. Dis. 22, 108\u2013114 (2004).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2011210_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1365-2036.2003.01770.x","volume":"18","author":"M Kulig","year":"2003","unstructured":"Kulig, M. et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment. Pharmacol. Ther. 18, 767\u2013776 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0016-5085(03)01126-0","volume":"125","author":"HR Koelz","year":"2003","unstructured":"Koelz, H. R., Blum, A. L. & Modlin, I. M. Costs of gerd: facts and fiction. Gastroenterology 125, 981\u2013982 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/gut.2009.200063","volume":"59","author":"J Dent","year":"2010","unstructured":"Dent, J. et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut 59, 714\u2013721 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000103879","volume":"25","author":"V Savarino","year":"2007","unstructured":"Savarino, V., Savarino, E., Parodi, A. & Dulbecco, P. Functional heartburn and non-erosive reflux disease. Dig. Dis. 25, 172\u2013174 (2007).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2011210_CR10","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","volume":"112","author":"GR Locke III","year":"1997","unstructured":"Locke, G. R. III, Talley, N. J., Fett, S. L., Zinsmeister, A. R. & Melton, L. J. 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112, 1448\u20131456 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000121354","volume":"26","author":"H Neumann","year":"2008","unstructured":"Neumann, H., Monkemuller, K., Kandulski, A. & Malfertheiner, P. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Dig. Dis. 26, 243\u2013247 (2008).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2011210_CR12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1053\/j.gastro.2005.08.060","volume":"130","author":"JP Galmiche","year":"2006","unstructured":"Galmiche, J. P. et al. Functional esophageal disorders. Gastroenterology 130, 1459\u20131465 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ajg.2010.476","volume":"106","author":"MF Vela","year":"2011","unstructured":"Vela, M. F., Craft, B. M., Sharma, N., Freeman, J. & Hazen-Martin, D. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am. J. Gastroenterol. 106, 844\u2013850 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/00365520510011579","volume":"40","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen, J. et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand. J. Gastroenterol. 40, 275\u2013285 (2005).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2006.08.032","volume":"131","author":"P Sharma","year":"2006","unstructured":"Sharma, P. et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 131, 1392\u20131399 (2006).","journal-title":"Gastroenterology."},{"key":"BFnrgastro2011210_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/gast.2002.31599","volume":"122","author":"JA Jankowski","year":"2002","unstructured":"Jankowski, J. A., Provenzale, D. & Moayyedi, P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 122, 588\u2013590 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/aje\/kwn121","volume":"168","author":"F Yousef","year":"2008","unstructured":"Yousef, F. et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am. J. Epidemiol. 168, 237\u2013249 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrgastro2011210_CR18","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1111\/j.1572-0241.2006.00829.x","volume":"101","author":"J Labenz","year":"2006","unstructured":"Labenz, J. et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am. J. Gastroenterol. 101, 2457\u20132462 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR19","unstructured":"Malfertheiner, P. et al. Evolution of gastroesophageal reflux disease (GERD) over 5 years under routine medical care\u2014the ProGERD study. Aliment. Pharmacol. Ther. (in press)."},{"key":"BFnrgastro2011210_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1572-0241.2006.00442.x","volume":"101","author":"SR Orenstein","year":"2006","unstructured":"Orenstein, S. R., Shalaby, T. M., Kelsey, S. F. & Frankel, E. Natural history of infant reflux esophagitis: symptoms and morphometric histology during one year without pharmacotherapy. Am. J. Gastroenterol. 101, 628\u2013640 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR21","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ajg.2009.129","volume":"104","author":"PM Sherman","year":"2009","unstructured":"Sherman, P. M. et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am. J. Gastroenterol. 104, 1278\u20131295 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR22","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J. & Jones, R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 101, 1900\u20131920 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR23","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1111\/j.1572-0241.2001.04095.x","volume":"96","author":"D Sifrim","year":"2001","unstructured":"Sifrim, D. & Holloway, R. Transient lower esophageal sphincter relaxations: how many or how harmful? Am. J. Gastroenterol. 96, 2529\u20132532 (2001).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR24","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1056\/NEJMoa054391","volume":"354","author":"BC Jacobson","year":"2006","unstructured":"Jacobson, B. C., Somers, S. C., Fuchs, C. S., Kelly, C. P. & Camargo, C. A. Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N. Engl. J. Med. 354, 2340\u20132348 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2011210_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","volume":"143","author":"H Hampel","year":"2005","unstructured":"Hampel, H., Abraham, N. S. & el-Serag, H. B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann. Intern. Med. 143, 199\u2013211 (2005).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2011210_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1053\/j.gastro.2004.08.014","volume":"128","author":"WJ Barlow","year":"2005","unstructured":"Barlow, W. J. & Orlando, R. C. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 128, 771\u2013778 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000219365","volume":"80","author":"IM Modlin","year":"2009","unstructured":"Modlin, I. M. et al. Diagnosis and management of non-erosive reflux disease - the Vevey NERD Consensus Group. Digestion 80, 74\u201388 (2009).","journal-title":"Digestion"},{"key":"BFnrgastro2011210_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ajg.2010.65","volume":"105","author":"PJ Kahrilas","year":"2010","unstructured":"Kahrilas, P. J. & Smout, A. J. Esophageal disorders. Am. J. Gastroenterol. 105, 747\u2013756 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","volume":"2","author":"BB Dean","year":"2004","unstructured":"Dean, B. B., Gano, A. D. Jr, Knight, K., Ofman, J. J. & Fass, R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin. Gastroenterol. Hepatol. 2, 656\u2013664 (2004).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.2007.145581","volume":"58","author":"R Fass","year":"2009","unstructured":"Fass, R. & Sifrim, D. Management of heartburn not responding to proton pump inhibitors. Gut 58, 295\u2013309 (2009).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bpg.2007.01.007","volume":"21","author":"AJ Smout","year":"2007","unstructured":"Smout, A. J. The patient with GORD and chronically recurrent problems. Best Pract. Res. Clin. Gastroenterol. 21, 365\u2013378 (2007).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"BFnrgastro2011210_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/0016-5085(89)90890-1","volume":"96","author":"JL Smith","year":"1989","unstructured":"Smith, J. L., Opekun, A. R., Larkai, E. & Graham, D. Y. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 96, 683\u2013689 (1989).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1365-2036.2003.01423.x","volume":"17","author":"SD Martinez","year":"2003","unstructured":"Martinez, S. D., Malagon, I. B., Garewal, H. S., Cui, H. & Fass, R. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns. Aliment. Pharmacol. Ther. 17, 537\u2013545 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gut.2003.033290","volume":"53","author":"D Sifrim","year":"2004","unstructured":"Sifrim, D., Castell, D., Dent, J. & Kahrilas, P. J. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53, 1024\u20131031 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1442-2050.2009.00940.x","volume":"22","author":"A Agrawal","year":"2009","unstructured":"Agrawal, A. et al. Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis. Esophagus 22, 467\u2013470 (2009).","journal-title":"Dis. Esophagus"},{"key":"BFnrgastro2011210_CR36","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1053\/gast.2001.24840","volume":"120","author":"MF Vela","year":"2001","unstructured":"Vela, M. F. et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120, 1599\u20131606 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR37","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1053\/gast.2001.24841","volume":"120","author":"D Sifrim","year":"2001","unstructured":"Sifrim, D. et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 120, 1588\u20131598 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/gut.2005.074690","volume":"55","author":"AJ Bredenoord","year":"2006","unstructured":"Bredenoord, A. J., Weusten, B. L., Curvers, W. L., Timmer, R. & Smout, A. J. Determinants of perception of heartburn and regurgitation. Gut 55, 313\u2013318 (2006).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR39","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1136\/gut.2005.087668","volume":"55","author":"I Mainie","year":"2006","unstructured":"Mainie, I. et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55, 1398\u20131402 (2006).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cgh.2008.01.006","volume":"6","author":"N Sharma","year":"2008","unstructured":"Sharma, N., Agrawal, A., Freeman, J., Vela, M. F. & Castell, D. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin. Gastroenterol. Hepatol. 6, 521\u2013524 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR41","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1111\/j.1572-0241.2008.02033.x","volume":"103","author":"GJ Hemmink","year":"2008","unstructured":"Hemmink, G. J. et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Am. J. Gastroenterol. 103, 2446\u20132453 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1067\/mcp.2002.127637","volume":"72","author":"T Furuta","year":"2002","unstructured":"Furuta, T. et al. Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin. Pharmacol. Ther. 72, 453\u2013460 (2002).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00228-009-0628-5","volume":"65","author":"T Furuta","year":"2009","unstructured":"Furuta, T. et al. CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole. Eur. J. Clin. Pharmacol. 65, 693\u2013698 (2009).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BFnrgastro2011210_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","volume":"22","author":"R Fass","year":"2005","unstructured":"Fass, R., Shapiro, M., Dekel, R. & Sewell, J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease\u2014where next? Aliment. Pharmacol. Ther. 22, 79\u201394 (2005).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0016-5085(70)80004-X","volume":"58","author":"F Ismail-Beigi","year":"1970","unstructured":"Ismail-Beigi, F., Horton, P. F. & Pope, C. E. Histological consequences of gastroesophageal reflux in man. Gastroenterology 58, 163\u2013174 (1970).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/path.1711290402","volume":"129","author":"D Hopwood","year":"1979","unstructured":"Hopwood, D., Milne, G. & Logan, K. R. Electron microscopic changes in human oesophageal epithelium in oesophagitis. J. Pathol. 129, 161\u2013167 (1979).","journal-title":"J. Pathol."},{"key":"BFnrgastro2011210_CR47","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1053\/gast.1996.v111.pm8898633","volume":"111","author":"NA Tobey","year":"1996","unstructured":"Tobey, N. A., Carson, J. L., Alkiek, R. A. & Orlando, R. C. Dilated intercellular spaces: a morphological feature of acid reflux\u2014damaged human esophageal epithelium. Gastroenterology 111, 1200\u20131205 (1996).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1572-0241.2003.04018.x","volume":"99","author":"NA Tobey","year":"2004","unstructured":"Tobey, N. A. et al. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am. J. Gastroenterol. 99, 13\u201322 (2004).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000080321","volume":"22","author":"M Vieth","year":"2004","unstructured":"Vieth, M. et al. Radial distribution of dilated intercellular spaces of the esophageal squamous epithelium in patients with reflux disease exhibiting discrete endoscopic lesions. Dig. Dis. 22, 208\u2013212 (2004).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2011210_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000080319","volume":"22","author":"M Vieth","year":"2004","unstructured":"Vieth, M. et al. What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa? Dig. Dis. 22, 196\u2013201 (2004).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2011210_CR51","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1365-2036.2004.02000.x","volume":"19","author":"P Zentilin","year":"2004","unstructured":"Zentilin, P. et al. Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. Aliment. Pharmacol. Ther. 19, 1285\u20131292 (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.humpath.2009.07.016","volume":"41","author":"R Fiocca","year":"2010","unstructured":"Fiocca, R. et al. Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum. Pathol. 41, 223\u2013231 (2010).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro2011210_CR53","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s10620-011-1624-z","volume":"56","author":"L Yerian","year":"2011","unstructured":"Yerian, L. et al. Refinement and reproducibility of histologic criteria for the assessment of microscopic lesions in patients with gastroesophageal reflux disease: the esohisto project. Dig. Dis. Sci. 56, 2656\u20132665 (2011).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2011210_CR54","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/ajg.2009.631","volume":"105","author":"R Fiocca","year":"2010","unstructured":"Fiocca, R. et al. Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial. Am. J. Gastroenterol. 105, 1015\u20131023 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR55","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2011.626","volume":"305","author":"JP Galmiche","year":"2011","unstructured":"Galmiche, J. P. et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305, 1969\u20131977 (2011).","journal-title":"JAMA"},{"key":"BFnrgastro2011210_CR56","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/gut.2007.141804","volume":"57","author":"R Farre","year":"2008","unstructured":"Farre, R. et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 57, 1366\u20131374 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR57","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1442-2050.2008.00841.x","volume":"21","author":"NA Tobey","year":"2008","unstructured":"Tobey, N. A., Gambling, T. M., Vanegas, X. C., Carson, J. L. & Orlando, R. C. Physicochemical basis for dilated intercellular spaces in non-erosive acid-damaged rabbit esophageal epithelium. Dis. Esophagus 21, 757\u2013764 (2008).","journal-title":"Dis. Esophagus"},{"key":"BFnrgastro2011210_CR58","first-page":"198","volume":"45","author":"CN Carney","year":"1981","unstructured":"Carney, C. N., Orlando, R. C., Powell, D. W. & Dotson, M. M. Morphologic alterations in early acid-induced epithelial injury of the rabbit esophagus. Lab. Invest. 45, 198\u2013208 (1981).","journal-title":"Lab. Invest."},{"key":"BFnrgastro2011210_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/gut.2009.194191","volume":"59","author":"R Farre","year":"2010","unstructured":"Farre, R. et al. Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut 59, 164\u2013169 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/gut.2010.233049","volume":"60","author":"R Farre","year":"2011","unstructured":"Farre, R. et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut 60, 885\u2013892 (2011).","journal-title":"Gut"},{"issue":"Suppl. 4a","key":"BFnrgastro2011210_CR61","doi-asserted-by":"publisher","first-page":"109S","DOI":"10.1016\/S0002-9343(99)00346-0","volume":"108","author":"RC Haggitt","year":"2000","unstructured":"Haggitt, R. C. Histopathology of reflux-induced esophageal and supraesophageal injuries. Am. J. Med. 108 (Suppl. 4a), 109S\u2013111S (2000).","journal-title":"Am. J. Med."},{"key":"BFnrgastro2011210_CR62","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1111\/j.1572-0241.2005.50096.x","volume":"100","author":"RD Odze","year":"2005","unstructured":"Odze, R. D. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am. J. Gastroenterol. 100, 1853\u20131867 (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ajcp\/87.1.43","volume":"87","author":"V Tummala","year":"1987","unstructured":"Tummala, V., Barwick, K. W., Sontag, S. J., Vlahcevic, R. Z. & McCallum, R. W. The significance of intraepithelial eosinophils in the histologic diagnosis of gastroesophageal reflux. Am. J. Clin. Pathol. 87, 43\u201348 (1987).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrgastro2011210_CR64","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0016-5085(19)31507-0","volume":"73","author":"EM Livstone","year":"1977","unstructured":"Livstone, E. M., Sheahan, D. G. & Behar, J. Studies of esophageal epithelial cell proliferation in patients with reflux esophagitis. Gastroenterology 73, 1315\u20131319 (1977).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR65","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1111\/j.1572-0241.2001.05260.x","volume":"96","author":"NA Tobey","year":"2001","unstructured":"Tobey, N. A. et al. The role of pepsin in acid injury to esophageal epithelium. Am. J. Gastroenterol. 96, 3062\u20133070 (2001).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR66","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/MCG.0b013e31815d0628","volume":"42","author":"RC Orlando","year":"2008","unstructured":"Orlando, R. C. Pathophysiology of gastroesophageal reflux disease. J. Clin. Gastroenterol. 42, 584\u2013588 (2008).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2011210_CR67","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/gut.47.6.870","volume":"47","author":"RC Fitzgerald","year":"2000","unstructured":"Fitzgerald, R. C. Inflammation at the neo squamocolumnar junction in Barrett's oesophagus. Gut 47, 870 (2000).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR68","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/gut.50.4.451","volume":"50","author":"RC Fitzgerald","year":"2002","unstructured":"Fitzgerald, R. C. et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 50, 451\u2013459 (2002).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR69","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1007\/s10620-009-0746-z","volume":"54","author":"A Kandulski","year":"2009","unstructured":"Kandulski, A. et al. Chronic mucosal inflammation of the gastric cardia in gastroesophageal reflux disease is not regulated by FOXP3-expressing T cells. Dig. Dis. Sci. 54, 1940\u20131946 (2009).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2011210_CR70","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1572-0241.2003.07303.x","volume":"98","author":"H Isomoto","year":"2003","unstructured":"Isomoto, H. et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am. J. Gastroenterol. 98, 551\u2013556 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR71","first-page":"335","volume":"19","author":"N Yoshida","year":"2007","unstructured":"Yoshida, N. et al. Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int. J. Mol. Med. 19, 335\u2013340 (2007).","journal-title":"Int. J. Mol. Med."},{"key":"BFnrgastro2011210_CR72","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000211714","volume":"79","author":"K Monkemuller","year":"2009","unstructured":"Monkemuller, K. et al. Interleukin-1\u03b2 and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients with erosive and non-erosive reflux disease. Digestion 79, 186\u2013195 (2009).","journal-title":"Digestion"},{"key":"BFnrgastro2011210_CR73","first-page":"71","volume":"16","author":"T Yamaguchi","year":"2005","unstructured":"Yamaguchi, T. et al. Cytokine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats. Int. J. Mol. Med. 16, 71\u201377 (2005).","journal-title":"Int. J. Mol. Med."},{"key":"BFnrgastro2011210_CR74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.gastro.2006.10.009","volume":"132","author":"F Rieder","year":"2007","unstructured":"Rieder, F. et al. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 132, 154\u2013165 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR75","doi-asserted-by":"publisher","first-page":"G1307","DOI":"10.1152\/ajpgi.00576.2005","volume":"290","author":"L Cheng","year":"2006","unstructured":"Cheng, L. et al. HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1307\u2013G1317 (2006).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2011210_CR76","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1572-0241.2004.04110.x","volume":"99","author":"H Isomoto","year":"2004","unstructured":"Isomoto, H. et al. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am. J. Gastroenterol. 99, 589\u2013597 (2004).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR77","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/archsurg.142.6.554","volume":"142","author":"DS Oh","year":"2007","unstructured":"Oh, D. S. et al. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. Arch. Surg. 142, 554\u2013559 (2007).","journal-title":"Arch. Surg."},{"key":"BFnrgastro2011210_CR78","doi-asserted-by":"publisher","first-page":"L566","DOI":"10.1152\/ajplung.00233.2002","volume":"284","author":"N Mukaida","year":"2003","unstructured":"Mukaida, N. Pathophysiological roles of interleukin-8\/CXCL8 in pulmonary diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L566\u2013L577 (2003).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnrgastro2011210_CR79","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000075698","volume":"68","author":"M Hamaguchi","year":"2003","unstructured":"Hamaguchi, M. et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 68, 189\u2013197 (2003).","journal-title":"Digestion"},{"key":"BFnrgastro2011210_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1124\/jpet.106.106104","volume":"319","author":"L Cheng","year":"2006","unstructured":"Cheng, L. et al. Acid-induced release of platelet-activating factor by human esophageal mucosa induces inflammatory mediators in circular smooth muscle. J. Pharmacol. Exp. Ther. 319, 117\u2013126 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrgastro2011210_CR81","doi-asserted-by":"publisher","first-page":"G860","DOI":"10.1152\/ajpgi.00260.2005","volume":"289","author":"L Cheng","year":"2005","unstructured":"Cheng, L. et al. In vitro model of acute esophagitis in the cat. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G860\u2013G869 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2011210_CR82","doi-asserted-by":"publisher","first-page":"G571","DOI":"10.1152\/ajpgi.00454.2009","volume":"298","author":"F Rieder","year":"2010","unstructured":"Rieder, F., Biancani, P., Harnett, K., Yerian, L. & Falk, G. W. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G571\u2013G581 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2011210_CR83","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/ajg.2010.265","volume":"105","author":"A Kandulski","year":"2010","unstructured":"Kandulski, A. et al. Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease. Am. J. Gastroenterol. 105, 1934\u20131943 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR84","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1053\/j.gastro.2009.07.055","volume":"137","author":"RF Souza","year":"2009","unstructured":"Souza, R. F. et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 137, 1776\u20131784 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR85","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1080\/00365520410006729","volume":"39","author":"N Yoshida","year":"2004","unstructured":"Yoshida, N. et al. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand. J. Gastroenterol. 39, 816\u2013822 (2004).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/72247","volume":"6","author":"M Steinhoff","year":"2000","unstructured":"Steinhoff, M. et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6, 151\u2013158 (2000).","journal-title":"Nat. Med."},{"key":"BFnrgastro2011210_CR87","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/00365520801942141","volume":"43","author":"K Soreide","year":"2008","unstructured":"Soreide, K. Proteinase-activated receptor 2 (PAR-2) in gastrointestinal and pancreatic pathophysiology, inflammation and neoplasia. Scand. J. Gastroenterol. 43, 902\u2013909 (2008).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR88","doi-asserted-by":"crossref","first-page":"13146","DOI":"10.1016\/S0021-9258(18)42184-9","volume":"267","author":"RM Scarborough","year":"1992","unstructured":"Scarborough, R. M. et al. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J. Biol. Chem. 267, 13146\u201313149 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2011210_CR89","doi-asserted-by":"publisher","first-page":"C1429","DOI":"10.1152\/ajpcell.1998.274.6.C1429","volume":"274","author":"O Dery","year":"1998","unstructured":"Dery, O., Corvera, C. U., Steinhoff, M. & Bunnett, N. W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274, C1429\u2013C1452 (1998).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro2011210_CR90","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0002-9440(10)64466-5","volume":"161","author":"N Cenac","year":"2002","unstructured":"Cenac, N. et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161, 1903\u20131915 (2002).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro2011210_CR91","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/89945","volume":"7","author":"N Vergnolle","year":"2001","unstructured":"Vergnolle, N. et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. 7, 821\u2013826 (2001).","journal-title":"Nat. Med."},{"key":"BFnrgastro2011210_CR92","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1053\/gast.2002.32387","volume":"122","author":"AM Coelho","year":"2002","unstructured":"Coelho, A. M., Vergnolle, N., Guiard, B., Fioramonti, J. & Bueno, L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 122, 1035\u20131047 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR93","doi-asserted-by":"publisher","first-page":"31936","DOI":"10.1074\/jbc.M506338200","volume":"280","author":"C Jacob","year":"2005","unstructured":"Jacob, C. et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and \u03b2-arrestins. J. Biol. Chem. 280, 31936\u201331948 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2011210_CR94","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/gut.2007.120691","volume":"56","author":"JD Soderholm","year":"2007","unstructured":"Soderholm, J. D. Stress-related changes in oesophageal permeability: filling the gaps of GORD? Gut 56, 1177\u20131180 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR95","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/ajg.2010.272","volume":"105","author":"RF Souza","year":"2010","unstructured":"Souza, R. F. Bringing GERD management up to PAR-2. Am. J. Gastroenterol. 105, 1944\u20131946 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR96","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00535-005-1742-5","volume":"41","author":"Y Naito","year":"2006","unstructured":"Naito, Y. et al. Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats. J. Gastroenterol. 41, 198\u2013208 (2006).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2011210_CR97","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1523\/JNEUROSCI.5679-03.2004","volume":"24","author":"S Amadesi","year":"2004","unstructured":"Amadesi, S. et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J. Neurosci. 24, 4300\u20134312 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrgastro2011210_CR98","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00042737-200603000-00006","volume":"18","author":"YM Bhat","year":"2006","unstructured":"Bhat, Y. M. & Bielefeldt, K. Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur. J. Gastroenterol. Hepatol. 18, 263\u2013270 (2006).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR99","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00042737-200409000-00014","volume":"16","author":"PJ Matthews","year":"2004","unstructured":"Matthews, P. J. et al. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur. J. Gastroenterol. Hepatol. 16, 897\u2013902 (2004).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR100","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1365-2982.2010.01514.x","volume":"22","author":"MP Guarino","year":"2010","unstructured":"Guarino, M. P. et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol. Motil. 22, 746\u2013751, e219 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2011210_CR101","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","volume":"271","author":"DN Cortright","year":"2004","unstructured":"Cortright, D. N. & Szallasi, A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur. J. Biochem. 271, 1814\u20131819 (2004).","journal-title":"Eur. J. Biochem."},{"key":"BFnrgastro2011210_CR102","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1365-2982.2009.01332.x","volume":"21","author":"S Kindt","year":"2009","unstructured":"Kindt, S., Vos, R., Blondeau, K. & Tack, J. Influence of intra-oesophageal capsaicin instillation on heartburn induction and oesophageal sensitivity in man. Neurogastroenterol. Motil. 21, 1032\u2013e82 (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2011210_CR103","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(00)04503-7","volume":"357","author":"Y Yiangou","year":"2001","unstructured":"Yiangou, Y. et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 357, 1338\u20131339 (2001).","journal-title":"Lancet"},{"key":"BFnrgastro2011210_CR104","doi-asserted-by":"publisher","first-page":"G135","DOI":"10.1152\/ajpgi.90386.2008","volume":"297","author":"L Cheng","year":"2009","unstructured":"Cheng, L. et al. HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G135\u2013G143 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2011210_CR105","doi-asserted-by":"publisher","first-page":"G233","DOI":"10.1152\/ajpgi.00409.2009","volume":"298","author":"J Ma","year":"2010","unstructured":"Ma, J., Harnett, K. M., Behar, J., Biancani, P. & Cao, W. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G233\u2013G240 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2011210_CR106","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1365-2982.2010.01530.x","volume":"22","author":"KR Shieh","year":"2010","unstructured":"Shieh, K. R. et al. Evidence for neurotrophic factors associating with TRPV1 gene expression in the inflamed human esophagus. Neurogastroenterol. Motil. 22, 971\u20137, e252 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2011210_CR107","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/gut.52.10.1397","volume":"52","author":"GH Koek","year":"2003","unstructured":"Koek, G. H., Sifrim, D., Lerut, T., Janssens, J. & Tack, J. Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52, 1397\u20131402 (2003).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR108","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-2036.2003.01394.x","volume":"17","author":"MF Vela","year":"2003","unstructured":"Vela, M. F., Tutuian, R., Katz, P. O. & Castell, D. O. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment. Pharmacol. Ther. 17, 243\u2013251 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR109","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/ajg.2009.718","volume":"105","author":"LB Gerson","year":"2010","unstructured":"Gerson, L. B. et al. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. Am. J. Gastroenterol. 105, 1266\u20131275 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2011210_CR110","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1053\/j.gastro.2010.04.051","volume":"139","author":"GE Boeckxstaens","year":"2010","unstructured":"Boeckxstaens, G. E. et al. Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology 139, 409\u2013417 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR111","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1365-2036.2011.04596.x","volume":"33","author":"F Zerbib","year":"2011","unstructured":"Zerbib, F. et al. Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 33, 911\u2013921 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR112","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1365-2982.2010.01484.x","volume":"22","author":"F Zerbib","year":"2010","unstructured":"Zerbib, F., Keywood, C. & Strabach, G. Efficacy, tolerability and pharmacokinetics of a modified release formulation of ADX10059, a negative allosteric modulator of metabotropic glutamate receptor 5: an esophageal pH-impedance study in healthy subjects. Neurogastroenterol. Motil. 22, 859\u2013865, e231 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro2011210_CR113","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2008.162040","volume":"58","author":"C Keywood","year":"2009","unstructured":"Keywood, C., Wakefield, M. & Tack, J. A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease. Gut 58, 1192\u20131199 (2009).","journal-title":"Gut"},{"key":"BFnrgastro2011210_CR114","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-2036.1998.00268.x","volume":"12","author":"M Ruth","year":"1998","unstructured":"Ruth, M., Hamelin, B., Rohss, K. & Lundell, L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 12, 35\u201340 (1998).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR115","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00042737-200310000-00009","volume":"15","author":"M Ruth","year":"2003","unstructured":"Ruth, M., Finizia, C., Cange, L. & Lundell, L. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur. J. Gastroenterol. Hepatol. 15, 1115\u20131121 (2003).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2011210_CR116","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.mcg.0000210103.82241.97","volume":"40","author":"YK Cho","year":"2006","unstructured":"Cho, Y. K. et al. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers. J. Clin. Gastroenterol. 40, 286\u2013292 (2006).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2011210_CR117","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1053\/gast.2002.36025","volume":"123","author":"A Lehmann","year":"2002","unstructured":"Lehmann, A. et al. Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs. Gastroenterology 123, 1129\u20131134 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011210_CR118","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1113\/jphysiol.2003.042242","volume":"550","author":"ER Partosoedarso","year":"2003","unstructured":"Partosoedarso, E. R., Abrahams, T. P., Scullion, R. T., Moerschbaecher, J. M. & Hornby, P. J. Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J. Physiol. 550, 149\u2013158 (2003).","journal-title":"J. Physiol."},{"key":"BFnrgastro2011210_CR119","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1476-5381.2008.00010.x","volume":"156","author":"H Beaumont","year":"2009","unstructured":"Beaumont, H. et al. Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans. Br. J. Pharmacol. 156, 153\u2013162 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrgastro2011210_CR120","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2036.2011.04576.x","volume":"33","author":"E Scarpellini","year":"2011","unstructured":"Scarpellini, E. et al. Effect of rimonabant on oesophageal motor function in man. Aliment. Pharmacol. Ther. 33, 730\u2013737 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR121","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2036.2006.02772.x","volume":"23","author":"D Broekaert","year":"2006","unstructured":"Broekaert, D., Fischler, B., Sifrim, D., Janssens, J. & Tack, J. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 23, 365\u2013370 (2006).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2011210_CR122","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1365-2036.2011.04629.x","volume":"33","author":"AL Krarup","year":"2011","unstructured":"Krarup, A. L. et al. Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment. Pharmacol. Ther. 33, 1113\u20131122 (2011).","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2011.210","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2011.210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2011.210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:42:58Z","timestamp":1684467778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2011.210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,22]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFnrgastro2011210"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2011.210","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,22]]}}}